dorsaVi Licenses Human Robot Collaboration IP
Filed with ASX · · 6 pages · English
Summary by 6ix AI
dorsaVi Ltd. has announced the licensing of two robotics intellectual property assets from Nanyang Technological University Singapore to enhance its collaborative robotics and exoskeleton strategy. This strategic move aims to expand dorsaVi's market presence in high-growth sectors such as collaborative robotics and rehabilitation, leveraging its existing clinical data and technology. The CEO emphasized that this license completes a critical part of their strategy to integrate sensing, control, and learning capabilities into a cohesive robotics platform.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from dorsaVi
- RRAM Tech Evaluation Indicates 2x Battery Life in Robotics
- DVL RRAM Showcases Stable Performance in Temperature Testing
- DVL Marks Major Milestone to 22nm RRAM Commercialisation
- DVL Advances US Dept of Defense Military Injury Program
- DVL advances modular ultra-edge hardware platform
Later from dorsaVi
- DorsaVi Limited (ASX: DVL) Licenses NTU Singapore Robotics IP to Accelerate Exoskeleton and Collaborative Robotics Strategy
- dorsaVi Well Funded Following $500k Options Exercise
- dorsaVi Finalises RRAM-CMOS Validation Chip Design
- dorsaVi Commences Tape-Out of Validation Chip
- dorsaVi v6.5 Sensor Advances Physical AI Strategy
Follow dorsaVi into a list and get an email when it puts out news.
Follow dorsaVi